Esperion Therapeutics, Inc.

ESPR

—

Advanced chart & tools →

Esperion Therapeutics, Inc.ESPR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.11

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$403.13M

Net income

$-22.68M

Net margin

-5.6%

Gross margin

—

Dividends & financials

Esperion Therapeutics, Inc. (ESPR) reported revenue of $403.13M and net income of $-22.68M, or $-0.11 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.